These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 21532195)

  • 1. A novel synthetic approach to very late antigen-4 antagonist trans-4-[1-[[2,5-dichloro-4-(1-methyl-3-indolylcarboxyamide)phenyl]acetyl]-(4S)-methoxy-(2S)-pyrrolidinylmethoxy]cyclohexanecarboxylic acid via tert-butyl trans-[(4S)-Methoxy-(2S)-pyrrolidinylmethoxy]cyclohexanecarboxylate as a key intermediate.
    Chiba J; Machinaga N
    Chem Pharm Bull (Tokyo); 2011; 59(5):574-8. PubMed ID: 21532195
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A concise synthesis of a very late antigen-4 antagonist trans-4-[1-[[2,5-dichloro-4-(1-methyl-3-indolylcarboxyamide)phenyl]acetyl]-(4S)-methoxy-(2S)-pyrrolidinylmethoxy]cyclohexanecarboxylic acid via reductive etherification.
    Chiba J; Muro F; Setoguchi M; Machinaga N
    Chem Pharm Bull (Tokyo); 2012; 60(7):882-6. PubMed ID: 22790822
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery of trans-4-[1-[[2,5-Dichloro-4-(1-methyl-3-indolylcarboxamido)phenyl]acetyl]-(4S)-methoxy-(2S)-pyrrolidinylmethoxy]cyclohexanecarboxylic acid: an orally active, selective very late antigen-4 antagonist.
    Muro F; Iimura S; Sugimoto Y; Yoneda Y; Chiba J; Watanabe T; Setoguchi M; Iigou Y; Matsumoto K; Satoh A; Takayama G; Taira T; Yokoyama M; Takashi T; Nakayama A; Machinaga N
    J Med Chem; 2009 Dec; 52(24):7974-92. PubMed ID: 19891440
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of trans-4-[1-[[7-fluoro-2-(1-methyl-3-indolyl)-6-benzoxazolyl]acetyl]-(4S)-fluoro-(2S)-pyrrolidinylmethoxy]cyclohexanecarboxylic acid as a potent, orally active VLA-4 antagonist.
    Setoguchi M; Iimura S; Sugimoto Y; Yoneda Y; Chiba J; Watanabe T; Muro F; Iigo Y; Takayama G; Yokoyama M; Taira T; Aonuma M; Takashi T; Nakayama A; Machinaga N
    Bioorg Med Chem; 2012 Feb; 20(3):1201-12. PubMed ID: 22261021
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improvement of pulmonary function by oral treatment with a VLA-4 antagonist in a mouse asthmatic model.
    Takayama G; Matsumoto K; Taira T; Aonuma M; Yokoyama M; Iigo Y; Takashi T
    J Pharmacol Sci; 2013; 121(2):172-5. PubMed ID: 23419271
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel, potent, and orally active VLA-4 antagonist with good aqueous solubility: trans-4-[1-[[2-(5-Fluoro-2-methylphenylamino)-7-fluoro-6-benzoxazolyl]acetyl]-(5S)-[methoxy(methyl)amino]methyl-(2S)-pyrrolidinylmethoxy]cyclohexanecarboxylic acid.
    Setoguchi M; Iimura S; Sugimoto Y; Yoneda Y; Chiba J; Watanabe T; Muro F; Iigo Y; Takayama G; Yokoyama M; Taira T; Aonuma M; Takashi T; Nakayama A; Machinaga N
    Bioorg Med Chem; 2013 Jan; 21(1):42-61. PubMed ID: 23218775
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel and potent VLA-4 antagonist based on trans-4-substituted cyclohexanecarboxylic acid.
    Muro F; Iimura S; Yoneda Y; Chiba J; Watanabe T; Setoguchi M; Takayama G; Yokoyama M; Takashi T; Nakayama A; Machinaga N
    Bioorg Med Chem; 2009 Feb; 17(3):1232-43. PubMed ID: 19124247
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The absolute configuration of (2S,4S)- and (2R,4R)-2-tert-butyl-4-methyl-3-(4-tolylsulfonyl)-1,3-oxazolidine-4-carbaldehyde.
    Flock S; Bruhn C; Fink H; Frauenrath H
    Acta Crystallogr C; 2006 Feb; 62(Pt 2):o101-3. PubMed ID: 16456281
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of 4-[1-[3-chloro-4-[N'-(5-fluoro-2-methylphenyl)ureido]phenylacetyl]-(4S)-fluoro-(2S)-pyrrolidinylmethoxy]benzoic acid as a potent, orally active VLA-4 antagonist.
    Muro F; Iimura S; Yoneda Y; Chiba J; Watanabe T; Setoguchi M; Iigou Y; Takayama G; Yokoyama M; Takashi T; Nakayama A; Machinaga N
    Bioorg Med Chem; 2008 Dec; 16(23):9991-10000. PubMed ID: 18952443
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and pharmacological activity of 4-amino-5-chloro-2-methoxy-N-[(2S,4S)-1-ethyl-2-hydroxymethyl-4- pyrrolidinyl]benzamide (TKS159) and its optical isomers.
    Yanagi T; Kitajima A; Anzai K; Kodama K; Mizoguchi J; Fujiwara H; Sakiyama H; Kamoda O; Kamei C
    Chem Pharm Bull (Tokyo); 1999 Nov; 47(11):1650-4. PubMed ID: 10605060
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combinatorial solution-phase synthesis of (2S,4S)-4-acylamino-5-oxopyrrolidine-2-carboxamides.
    Malavasic C; Brulc B; Cebasek P; Dahmann G; Heine N; Bevk D; Groselj U; Meden A; Stanovnik B; Svete J
    J Comb Chem; 2007; 9(2):219-29. PubMed ID: 17348728
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis of 2,3-disubstituted pyrrolidines and piperidines via one-pot oxidative decarboxylation-beta-iodination of amino acids.
    Boto A; Hernández R; de León Y; Suárez E
    J Org Chem; 2001 Nov; 66(23):7796-803. PubMed ID: 11701038
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stereo-Selective Preparation of Teneraic Acid, trans-(2S,6S)-Piperidine-2,6-dicarboxylic Acid, via Anodic Oxidation and Cobalt-Catalyzed Carbonylation.
    Amino Y; Nishi S; Izawa K
    Chem Pharm Bull (Tokyo); 2017; 65(9):854-861. PubMed ID: 28867713
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Asymmetric synthesis of 3,4-anti- and 3,4-syn-substituted aminopyrrolidines via lithium amide conjugate addition.
    Davies SG; Garner AC; Goddard EC; Kruchinin D; Roberts PM; Smith AD; Rodriguez-Solla H; Thomson JE; Toms SM
    Org Biomol Chem; 2007 Jun; 5(12):1961-9. PubMed ID: 17551646
    [TBL] [Abstract][Full Text] [Related]  

  • 15. (2S,4R)- and (2S,4S)-perfluoro-tert-butyl 4-hydroxyproline: two conformationally distinct proline amino acids for sensitive application in 19F NMR.
    Tressler CM; Zondlo NJ
    J Org Chem; 2014 Jun; 79(12):5880-6. PubMed ID: 24870929
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determination of the stereochemistry of 2-succinyl-5-enolpyruvyl-6-hydroxy-3- cyclohexene-1-carboxylate, a key intermediate in menaquinone biosynthesis.
    Jiang M; Chen M; Cao Y; Yang Y; Sze KH; Chen X; Guo Z
    Org Lett; 2007 Nov; 9(23):4765-7. PubMed ID: 17956107
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enantioselective nitrile anion cyclization to substituted pyrrolidines. A highly efficient synthesis of (3S,4R)-N-tert-butyl-4-arylpyrrolidine-3-carboxylic acid.
    Chung JY; Cvetovich R; Amato J; McWilliams JC; Reamer R; DiMichele L
    J Org Chem; 2005 Apr; 70(9):3592-601. PubMed ID: 15844996
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 4-Fluoropyrrolidine-2-carbonyl fluorides: useful synthons and their facile preparation with 4-tert-butyl-2,6-dimethylphenylsulfur trifluoride.
    Singh RP; Umemoto T
    J Org Chem; 2011 May; 76(9):3113-21. PubMed ID: 21446739
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Marked strain differences in the pharmacokinetics of an alpha4beta1 integrin antagonist, 4-[1-[3-Chloro-4-[N-(2-methylphenyl)-ureido]phenylacetyl]-(4S)-fluoro-(2S)-pyrrolidine-2-yl]-methoxybenzoic Acid (D01-4582), in Sprague-Dawley rats are associated with albumin genetic polymorphism.
    Ito T; Takahashi M; Sudo K; Sugiyama Y
    J Pharmacol Exp Ther; 2007 Jan; 320(1):124-32. PubMed ID: 17038508
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conformationally constrained dipeptide surrogates with aromatic side-chains: synthesis of 4-aryl indolizidin-9-one amino acids by conjugate addition to a common alpha,omega-diaminoazelate enone intermediate.
    Cluzeau J; Lubell WD
    J Org Chem; 2004 Mar; 69(5):1504-12. PubMed ID: 14987004
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.